Cargando…
A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease
BACKGROUND: Value assessment of vaccination programs against serogroup B invasive meningococcal disease (IMD) is on the agenda of public health authorities. Current evidence on the burden due to IMD is unfit for pinning down the nature and magnitude of the full social and economic costs of IMD for t...
Autores principales: | Marten, Ole, Koerber, Florian, Bloom, David, Bullinger, Monika, Buysse, Corinne, Christensen, Hannah, De Wals, Philippe, Dohna-Schwake, Christian, Henneke, Philipp, Kirchner, Markus, Knuf, Markus, Lawrenz, Burkhard, Monteiro, Andrea L., Sevilla, Joseph Patrick, Van de Velde, Nicolas, Welte, Robert, Wright, Claire, Greiner, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532178/ https://www.ncbi.nlm.nih.gov/pubmed/31118091 http://dx.doi.org/10.1186/s12955-019-1159-0 |
Ejemplares similares
-
Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
por: Serra, Lidia, et al.
Publicado: (2021) -
Meningococcal disease serogroup C
por: Dickinson, Félix O, et al.
Publicado: (2012) -
Serogroup Y Meningococcal Disease, Colombia
por: Agudelo, Clara Inés, et al.
Publicado: (2008) -
Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
por: Knuf, Markus, et al.
Publicado: (2022) -
Serogroup X in Meningococcal Disease, Western Kenya
por: Materu, Sadiki, et al.
Publicado: (2007)